EU MDR INSIGHT: ANCILLARY DRUG SUBSTANCE, BIOLOGICALLY ACTIVE MATERIAL, AND DRUG DEVICE COMBINATION PRODUCTS
With the global combination product market size expected to reach USD 177.7 billion by 2024, and increasing technological innovation in the medical device market, it has become crucial to ensure that regulation for combination products reflects the evolving market and strengthens safety and efficacy. Accordingly, the new European Union Medical Device Regulation (MDR) 2017/745, which was published on May 5, 2017
Read more...